Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Ltd has reported its financial results for the second quarter of Fiscal Year 2026 (FY26), ending September 30, 2025. The company's net profit saw a modest rise of 5% to ₹91.83 crore, up from ₹87.45 crore in the same period last year. Revenue from operations increased by 5.7% to ₹443.9 crore, with a significant contribution from its domestic business, which grew by an impressive 16.9%.

However, Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) remained relatively flat, standing at ₹114.68 crore compared to ₹115.22 crore a year ago. Operating profit margins slightly decreased to 25.84% from 27.43% in the prior year's corresponding quarter.

Strategically, Poly Medicure launched eight new products and is expanding its innovation pipeline with over 80 R&D professionals. The company also strengthened its global presence by acquiring the PendraCare Group in the Netherlands (cardiology) and Citieffe Group in Italy (orthopaedics). Over 4,300 stents have been implanted from their portfolio this year, receiving positive clinical feedback. Furthermore, the company secured a 7.16-acre plot for a medical device park in YEIDA and launched the 'Polymed Academy of Clinical Excellence' (PACE) to enhance clinician training.

For the first half of FY26, consolidated operating EBITDA and PAT showed growth of 2.6% and 14.5% respectively, with EBITDA margins within the guided range of 25-27%.

Impact This news is moderately positive for Poly Medicure Ltd investors. The profit and revenue growth, coupled with strategic expansion through acquisitions and new product launches, signals potential for future growth. However, the flat EBITDA and slightly lower margins might be a point of concern. The stock's performance will likely depend on how effectively the company integrates its new acquisitions and capitalizes on its expanded product portfolio and market reach. Impact Rating: 6/10

Difficult Terms Explained: EBITDA: Stands for Earnings Before Interest, Tax, Depreciation, and Amortisation. It is a measure of a company's operating performance before accounting for non-operational expenses and non-cash charges. Operating Margins: This ratio indicates how much profit a company makes for every rupee of revenue generated from its core business operations. It is calculated as Operating Profit divided by Revenue. FY26: Fiscal Year 2026, which in India typically runs from April 1, 2025, to March 31, 2026. YEIDA: Yamuna Expressway Industrial Development Authority, a government body responsible for developing industrial and commercial areas in Uttar Pradesh, India. PACE: Polymed Academy of Clinical Excellence, an initiative by Poly Medicure for clinician training.